Chantest
Cleveland
About Chantest
ChanTest has developed the world's most complete library of validated human ion channel-expressing cell lines to serve all the ion channel needs of its pharmaceutical and biotech customers. Services range from early functional screens for profiling drug candidates or ranking within profiles during the drug-discovery process ’ to a complete set of in vitro GLP service products for cardiac risk assessment. ChanTest works in partnership with customers to speed the drug-development process, save time and money, and ultimately ’ to help make better, safer drugs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Funding stage: M&A
- Last round: Series Unknown (Aug 2007)
- Website: chantest.com
- Phone: 2163321706
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/chantest-2775958 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.